|
Oct 7
|
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30th, 2024
|
|
Feb 8
|
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024
|
|
Jan 10
|
Median Technologies: Half Year Liquidity Contract Statement
|
|
Dec 27
|
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
|
|
Dec 7
|
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2023
|
|
Nov 30
|
Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations
|
|
Nov 27
|
Median Technologies Selected for Support Under the French Government's ETIncelles Program
|
|
Nov 26
|
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
|
|
Nov 6
|
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2023
|